↓ Skip to main content

Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe

Overview of attention for article published in Orphanet Journal of Rare Diseases, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
94 Dimensions

Readers on

mendeley
95 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe
Published in
Orphanet Journal of Rare Diseases, July 2014
DOI 10.1186/1750-1172-9-99
Pubmed ID
Authors

Emel Aygören-Pürsün, Anette Bygum, Kathleen Beusterien, Emily Hautamaki, Zlatko Sisic, Suzanne Wait, Henrik B Boysen, Teresa Caballero

Abstract

Hereditary angioedema (HAE) due to C1 inhibitor deficiency is a rare but serious and potentially life-threatening disease marked by spontaneous, recurrent attacks of swelling. The study objective was to characterize direct and indirect resource utilization associated with HAE from the patient perspective in Europe.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Turkey 1 1%
Unknown 94 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 17%
Other 11 12%
Student > Master 10 11%
Student > Doctoral Student 8 8%
Student > Ph. D. Student 7 7%
Other 14 15%
Unknown 29 31%
Readers by discipline Count As %
Medicine and Dentistry 34 36%
Economics, Econometrics and Finance 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Nursing and Health Professions 4 4%
Agricultural and Biological Sciences 4 4%
Other 13 14%
Unknown 29 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2021.
All research outputs
#4,659,159
of 25,371,288 outputs
Outputs from Orphanet Journal of Rare Diseases
#644
of 3,105 outputs
Outputs of similar age
#42,817
of 242,211 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#14
of 48 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,105 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,211 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.